Testing for an Unusual Distribution of Rare Variants
Open Access
- 3 March 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 7 (3) , e1001322
Abstract
Technological advances make it possible to use high-throughput sequencing as a primary discovery tool of medical genetics, specifically for assaying rare variation. Still this approach faces the analytic challenge that the influence of very rare variants can only be evaluated effectively as a group. A further complication is that any given rare variant could have no effect, could increase risk, or could be protective. We propose here the C-alpha test statistic as a novel approach for testing for the presence of this mixture of effects across a set of rare variants. Unlike existing burden tests, C-alpha, by testing the variance rather than the mean, maintains consistent power when the target set contains both risk and protective variants. Through simulations and analysis of case/control data, we demonstrate good power relative to existing methods that assess the burden of rare variants in individuals. Developments in sequencing technology now enable us to assay all genetic variation, much of which is extremely rare. We propose to test the distribution of rare variants we observe in cases versus controls. To do so, we present a novel application of the C-alpha statistic to test these rare variants. C-alpha aims to determine whether the set of variants observed in cases and controls is a mixture, such that some of the variants confer risk or protection or are phenotypically neutral. Risk variants are expected to be more common in cases; protective variants more common in controls. C-alpha is sensitive to this imbalance, regardless of its origin—risk, protective, or both—but is ideally suited for a mixture of protective and risk variants. Variation in APOB nicely illustrates a mixture, in that certain rare variants increase triglyceride levels while others decrease it. The hallmark feature of C-alpha is that it uses the distribution of variation observed in cases and controls to detect the presence of a mixture, thus implicating genes or pathways as risk factors for disease.Keywords
This publication has 28 references indexed in Scilit:
- Pooled Association Tests for Rare Variants in Exon-Resequencing StudiesThe American Journal of Human Genetics, 2010
- In silico functional profiling of human disease-associated and polymorphic amino acid substitutionsHuman Mutation, 2010
- Exome sequencing identifies the cause of a mendelian disorderNature Genetics, 2009
- Power of deep, all-exon resequencing for discovery of human trait genesProceedings of the National Academy of Sciences, 2009
- A Groupwise Association Test for Rare Mutations Using a Weighted Sum StatisticPLOS Genetics, 2009
- Methods for Detecting Associations with Rare Variants for Common Diseases: Application to Analysis of Sequence DataThe American Journal of Human Genetics, 2008
- On the Use of General Control Samples for Genome-wide Association Studies: Genetic Matching Highlights Causal VariantsThe American Journal of Human Genetics, 2008
- Principal components analysis corrects for stratification in genome-wide association studiesNature Genetics, 2006
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseNew England Journal of Medicine, 2006
- XV.—The Correlation between Relatives on the Supposition of Mendelian Inheritance.Transactions of the Royal Society of Edinburgh, 1919